PT86344A - Substituierte aminopropionsaeureamide verfahren zu ihrer herstellung diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte - Google Patents

Substituierte aminopropionsaeureamide verfahren zu ihrer herstellung diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte

Info

Publication number
PT86344A
PT86344A PT86344A PT8634487A PT86344A PT 86344 A PT86344 A PT 86344A PT 86344 A PT86344 A PT 86344A PT 8634487 A PT8634487 A PT 8634487A PT 86344 A PT86344 A PT 86344A
Authority
PT
Portugal
Prior art keywords
aminoopropion
amidays
substituted
manufacture
acid
Prior art date
Application number
PT86344A
Other languages
German (de)
English (en)
Other versions
PT86344B (pt
Inventor
Rudolf Kunstmann
Franz Hock
Gabriele Wiemer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of PT86344A publication Critical patent/PT86344A/pt
Publication of PT86344B publication Critical patent/PT86344B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16Tryptamines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT86344A 1986-12-12 1987-12-11 Processo para a preparacao de amino-proprionamidas substituidas e de composicoes farmaceuticas que as contem, bem como de novos produtos intermedios utilizados na realizacao do processo PT86344B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863642497 DE3642497A1 (de) 1986-12-12 1986-12-12 Substituierte aminopropionsaeureamide, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte

Publications (2)

Publication Number Publication Date
PT86344A true PT86344A (de) 1988-01-01
PT86344B PT86344B (pt) 1990-11-07

Family

ID=6316060

Family Applications (1)

Application Number Title Priority Date Filing Date
PT86344A PT86344B (pt) 1986-12-12 1987-12-11 Processo para a preparacao de amino-proprionamidas substituidas e de composicoes farmaceuticas que as contem, bem como de novos produtos intermedios utilizados na realizacao do processo

Country Status (17)

Country Link
EP (1) EP0271099A3 (pt)
JP (1) JPS63185948A (pt)
KR (1) KR880007490A (pt)
AU (1) AU8246087A (pt)
DE (1) DE3642497A1 (pt)
DK (1) DK651987A (pt)
FI (1) FI875432A (pt)
HU (1) HUT45486A (pt)
IL (1) IL84791A0 (pt)
JO (1) JO1521B1 (pt)
MA (1) MA21130A1 (pt)
MT (1) MTP1014B (pt)
NO (1) NO875181D0 (pt)
OA (1) OA08699A (pt)
PT (1) PT86344B (pt)
TN (1) TNSN87138A1 (pt)
ZA (1) ZA879330B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039805A (en) * 1988-12-08 1991-08-13 Hoffmann-La Roche Inc. Novel benzoic and phenylacetic acid derivatives
US5149817A (en) * 1990-03-05 1992-09-22 Shionogi & Co., Ltd. Teirahydropyridine derivatives
US5189179A (en) 1990-08-29 1993-02-23 Merrell Dow Pharmaceuticals Inc. Serotonin 5ht1a agonists
AU3241093A (en) * 1992-01-07 1993-08-03 Merrell Dow Pharmaceuticals Inc. Treatment of involuntary movements with 5HT-1A receptor agonists
EP1118612A1 (en) * 2000-01-21 2001-07-25 Universita Degli Studi di Firenze Piperazine derivatives possesing nootropic activity
FR2976942B1 (fr) * 2011-06-23 2013-07-12 Metabolys Derives de piperazine, leurs procedes de preparation et leurs utilisations dans le traitement de l'insulinoresistance
CN111116451A (zh) * 2020-01-16 2020-05-08 宁波大学 一种多取代色胺基苯甲酰胺类化合物及其制备方法和用途
CN115322131B (zh) * 2022-04-21 2023-08-22 温州大学 β-氟代吲哚丙烯酰胺化合物的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8303946D0 (en) * 1983-02-12 1983-03-16 Recordati Chem Pharm Antihypertensive n-piperazinylalkanoylanilides
DE3500898A1 (de) * 1985-01-12 1986-07-17 Hoechst Ag, 6230 Frankfurt Neue propionsaeureamide mit saeuresekretionshemmender wirkung, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung

Also Published As

Publication number Publication date
EP0271099A3 (de) 1989-05-03
FI875432A0 (fi) 1987-12-10
FI875432A (fi) 1988-06-13
KR880007490A (ko) 1988-08-27
IL84791A0 (en) 1988-05-31
HUT45486A (en) 1988-07-28
EP0271099A2 (de) 1988-06-15
JPS63185948A (ja) 1988-08-01
JO1521B1 (en) 1989-01-25
DK651987D0 (da) 1987-12-11
MA21130A1 (fr) 1988-07-01
NO875181D0 (no) 1987-12-11
AU8246087A (en) 1988-08-18
DE3642497A1 (de) 1988-06-23
PT86344B (pt) 1990-11-07
ZA879330B (en) 1988-07-27
MTP1014B (en) 1989-07-18
TNSN87138A1 (fr) 1990-01-01
DK651987A (da) 1988-06-13
OA08699A (fr) 1989-03-31

Similar Documents

Publication Publication Date Title
DE3869205D1 (de) 2-phenylpurinon-derivate, verfahren zu ihrer herstellung, ihre verwendung sowie zwischenprodukte.
DE69211076T3 (de) Polyasparaginsäure-zusammensetzung, verfahren zu ihrer herstellung und ihre verwendung
ATA312987A (de) Brenzkatechin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneistoffe
DE3671627D1 (de) Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung.
DE58904567D1 (de) Quinuclidine, ihre verwendung als arzneimittel und verfahren zu ihrer herstellung.
ATA191889A (de) Fettsäurezusammensetzung, verfahren zu ihrer herstellung, ihre verwendung und pharmazeutische zusammensetzung, die sie enthält
DE59007520D1 (de) Sulfonsäuregruppenhaltige perylenverbindungen, verfahren zu ihrer herstellung und ihre verwendung.
DE3860503D1 (de) 10-dihydro-10-deoxo-11-azaerythronolid-a-verbindungen,verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung in arzneimitteln und in deren herstellung.
ATE32459T1 (de) Substituierte phenylsulfonyloxybenzimidazolcarbaminate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3581725D1 (de) Aminoacyllabdane, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE40826T1 (de) 4'-demethyl-4-epipodophyllotoxinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3382621D1 (de) Zwischenprodukte fuer die herstellung von cephemverbindungen, verfahren zu ihrer herstellung und ihre anwendung.
ATE9160T1 (de) Thienopyridinonderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
ATE1360T1 (de) Fungizide mittel, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide.
DE3677812D1 (de) Polyhydroxypolyether, verfahren zu ihrer herstellung und ihre verwendung.
PT86344A (de) Substituierte aminopropionsaeureamide verfahren zu ihrer herstellung diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte
DE3684334D1 (de) Antibiotika, "chloropolysporine b und c" genannt, ein verfahren zu ihrer herstellung und ihre therapeutische und veterinaere verwendung.
ATE38512T1 (de) Phenylen-substituierte, spergualinaehnliche derivate, verfahren zu ihrer herstellung und ihre verwendung als heilmittel.
DE3687515T2 (de) Oxa-, thia- und diazabicycloalkanderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE59002382D1 (de) Alkadiennitrile, verfahren zu ihrer herstellung und ihre verwendung.
DE68912944D1 (de) Phenylpyrole, verwendbar als arzneimittel, verfahren zu ihrer herstellung und ihre verwendung.
DE3484023D1 (de) Azolylmethylcycloalkane, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3682370D1 (de) 3-aminocarbonyl-1,4-dihydropyridin-5-carboxylsaeurederivate, verfahren zu ihrer herstellung, ihre verwendung und diese enthaltende pharmazeutische zusammensetzungen.
DE58902982D1 (de) N-sulfenylierte 2-amino-4-chlorthiazol-sulfonamide, ihre verwendung, verfahren zu ihrer herstellung und die dabei auftretenden zwischenprodukte 2,4-dichlor-thiazol-sulfonsaeurechlorid und 2-amino-4-chlor-thiazol-sulfonsaeureamid.
PT80906A (de) Substituierte guanidinobenzoesaeurephenylester verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19910921